Raipur , India, April 19, 2018 --
Report Sellers has added a new market research report “Global Artificial Intelligence in Diabetes Management Market: Drivers, Restraints, Opportunities, Trends, and Forecasts to 2023” to its offerings. The report is an in-depth market study providing accurate market insights including the latest trends, forecast, competitive insights, etc.
Market Overview
Digitization has made big data technologies more relevant in the healthcare context. The proliferation of smart devices has accelerated the transition to digitized healthcare. Smart apps have made self-management of diabetes by the patients affordable. Sensors are capable of transmitting data to the smart devices and diabetics can monitor their blood glucose levels on these devices. Pharmacogenetics and machine learning will help systems embedded with AI to manage diabetes better than humans within the next 20 years. AI algorithms bring about state-of-the-art glucose prediction methods that help in tackling diabetes effectively. They can mimic human cognitive functions. AI is leveraging the avalanche of healthcare data. AI is improving patient outcomes for diabetes patients. Data analytics is expected to make a disruptive impact in diabetes management.
Browse through the complete description and in-depth TOC on “Global Artificial Intelligence in Diabetes Management Market”
Market Analysis
The Global Artificial Intelligence in Diabetes Management market is expected to grow at a CAGR of 50.7% during the forecast period 2017-2023. The market is driven by factors such as rising elderly population, increasing obesity, favorable demographics, urbanization, rising healthcare costs, and increasing digital affinity. Patient’s privacy and security concerns, lack of curated datasets, and less digital savvy patients are few growth deterrents in the market. The market experiences few growth opportunities such as product innovations, democratization of knowledge, and rising prevalence of type 1 and type 2 diabetes.
We have a large number of reports in other Healthcare Industry which can be accessed in the following link:
https://www.reportsellers.com/category/healthcare-market-research-report
About Report Sellers
Report Sellers is a premium market research service provider offering market reports in varied sectors. We have a team of experienced analysts and publishers who continuously track the latest trends in different industries.
Report Sellers is a brand of global repute and offers the best suited research services to its clients globally in the most satisfying manner. We have a strong network of industry experts who have successfully delivered complex research assignments in niche and top markets.
Report Sellers Email: [email protected] Direct: +1-214-396-2385


Valero Energy Expands Venezuelan Crude Imports as U.S. Sanctions Ease
GE Aerospace Expands Singapore Engine Repair Hub with Automation and AI to Tackle Aviation Bottlenecks
How Marco Pharma International Preserves German Homeopathic Traditions in America
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
FTC Questions Apple News Over Alleged Bias Against Conservative Media
Converse Cuts Corporate Jobs as Nike Restructures to Revive Sales Growth
Anduril Eyes $60 Billion Valuation in New Funding Round to Expand Defense Manufacturing and Autonomous Fighter Jet Development
Westpac (ASX: WBC) Q1 Profit Rises 6% as Lending Growth and Treasury Income Strengthen Earnings
Lockheed Martin Secures $101M in U.S. Defense Contracts for AEGIS, F-35, and Missile Systems
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
Michael Kors Marks 45 Years at New York Fashion Week with Fall/Winter Collection Showcase
Vietnam Approves SpaceX Starlink Satellite Internet Service Amid U.S. Trade Talks
Sachem Head Boosts Warner Bros. Discovery Stake Amid Netflix Deal and Paramount Bid
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy
Paramount Skydance Appoints Rene Augustine as SVP of Global Public Policy Amid Warner Bros Takeover Battle
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Vale Reports $3.8 Billion Q4 Net Loss Amid Nickel Asset Impairment and Samarco Provisions 



